SARS-CoV-2 Testing for Asymptomatic Patients with Cancer Prior and during Treatment: A Single Centre Experience

Patients with cancer are more vulnerable to severe COVID-19. As a result, routine SARS-CoV-2 testing of asymptomatic patients with cancer is recommended prior to treatment. However, there is limited evidence of its clinical usefulness. The objective of this study is to evaluate the value of routine...

Descripción completa

Detalles Bibliográficos
Autores principales: Meti, Nicholas, Tahmasebi, Houman, Leahey, Angela, Boudreau, Angela, Thawer, Alia, Stewart, Janice, Reason, Paige, Albright, Kirsty, Leis, Jerome A., Katz, Kevin, Cheung, Matthew C., Singh, Simron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903264/
https://www.ncbi.nlm.nih.gov/pubmed/33419159
http://dx.doi.org/10.3390/curroncol28010032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903264/
https://www.ncbi.nlm.nih.gov/pubmed/33419159
http://dx.doi.org/10.3390/curroncol28010032

Ejemplares similares